A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure
Clinical trial NCT01096043 · COMPLETED
Trial details
- NCT number
- NCT01096043
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2012-02-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.